Post-transcriptional regulation of the DUSP6/MKP-3 phosphatase by MEK/ERK signaling and hypoxia

Journal of Cellular Physiology

Volumn 226, Issue 1, 2011, Pages 276-284

  Bermudez, Olga ^a   Jouandin, Patrick ^a   Rottier, Juliette ^a   Bourcier, Christine ^a   Pagès, Gilles ^a   Gimond, Clotilde ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 6; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TRISTETRAPROLIN;

3' UNTRANSLATED REGION; ARTICLE; HYPOXIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

CELL LINE; DUAL SPECIFICITY PHOSPHATASE 6; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MAP KINASE KINASE KINASES; PROTEIN STABILITY; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRISTETRAPROLIN;

DROSOPHILA PUMILIO;

EID: 78049253973     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22339     Document Type: Article

References (55)

1. Arkell RS, Dickinson RJ, Squires M, Hayat S, Keyse SM, Cook SJ. 2008. DUSP6/MKP-3 inactivates ERK1/2 but fails to bind and inactivate ERK5. Cell Signal 20: 836-843.
2. Bando H, Toi M, Kitada K, Koike M. 2003. Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231. Biomed Pharmacother 57: 333-340.
3. Bermudez O, Marchetti S, Pagès G, Gimond C. 2008. Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway. Oncogene 27: 3685-3691.
4. Bernaudin M, Tang Y, Reilly M, Petit E, Sharp FR. 2002. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem 277: 39728-39738.
5. Bloethner S, Chen B, Hemminki K, Müller-Berghaus J, Ugurel S, Schadendorf D, Kumar R. 2005. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Carcinogenesis 26: 1224-1232.
6. Brennan SE, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, Wilson GM. 2009. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res 69: 5168-5176.
7. Cagnol S, Van Obberghen-Schilling E, Chambard J. 2006. Prolonged activation of ERK1, 2 induces FADD-independent caspase 8 activation and cell death. Apoptosis 11: 337-346.
8. Camps M, Nichols A, Gillieron C, Antonsson B, Muda M, Chabert C, Boschert U, Arkinstall S. 1998. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280: 1262-1265.
9. Castelli M, Camps M, Gillieron C, Leroy D, Arkinstall S, Rommel C, Nichols A. 2004. MAP kinase phosphatase 3 (MKP3) interacts with and is phosphorylated by protein kinase CK2alpha. J Biol Chem 279: 44731-44739.
10. Chambard J, Lefloch R, Pouysségur J, Lenormand P. 2007. ERK implication in cell cycle regulation. Biochim Biophys Acta 1773: 1299-1310.
11. Chu S, Feng D, Ma Y, Zhu Z, Zhang H, Qiu J. 2009. Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1. Mol Biol Rep 36: 1967-1975.
12. Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, Pouysségur J, Lamarre J, Feige J. 2004. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 23: 8673-8680.
13. Croonquist PA, Linden MA, Zhao F, Van Ness BG. 2003. Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells. Blood 102: 2581-2592.
14. Dayan F, Roux D, Brahimi-Horn MC, Pouysségur J, Mazure NM. 2006. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res 66: 3688-3698.
15. Dickinson RJ, Eblaghie MC, Keyse SM, Morriss-Kay GM. 2002. Expression of the ERK-specific MAP kinase phosphatase PYST1/MKP3 in mouse embryos during morphogenesis and early organogenesis. Mech Dev 113: 193-196.
16. Eblaghie MC, Lunn JS, Dickinson RJ, Münsterberg AE, Sanz-Ezquerro JJ, Farrell ER, Mathers J, Keyse SM, Storey K, Tickle C. 2003. Negative feedback regulation of FGF signaling levels by Pyst1/MKP3 in chick embryos. Curr Biol 13: 1009-1018.
17. Ekerot M, Stavridis MP, Delavaine L, Mitchell MP, Staples C, Owens DM, Keenan ID, Dickinson RJ, Storey KG, Keyse SM. 2008. Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter. Biochem J 412: 287-298.
18. Emmons J, Townley-Tilson WHD, Deleault KM, Skinner SJ, Gross RH, Whitfield ML, Brooks SA. 2008. Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA 14: 888-902.
19. Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C, Pagès G. 2007. Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. Mol Biol Cell 18: 4648-4658.
20. Fjeld CC, Rice AE, Kim Y, Gee KR, Denu JM. 2000. Mechanistic basis for catalytic activation of mitogen-activated protein kinase phosphatase 3 by extracellular signal-regulated kinase. J Biol Chem 275: 6749-6757.
21. Furukawa T, Sunamura M, Motoi F, Matsuno S, Horii A. 2003. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am J Pathol 162: 1807-1815.
22. Furukawa T, Fujisaki R, Yoshida Y, Kanai N, Sunamura M, Abe T, Takeda K, Matsuno S, Horii A. 2005. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Mod Pathol 18: 1034-1042.
23. Furukawa T, Tanji E, Xu S, Horii A. 2008. Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells. Biochem Biophys Res Commun 377: 317-320.
24. Galgano A, Forrer M, Jaskiewicz L, Kanitz A, Zavolan M, Gerber AP. 2008. Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system. PLoS ONE 3: e3164.
25. Ghosh S, Spagnoli GC, Martin I, Ploegert S, Demougin P, Heberer M, Reschner A. 2005. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study. J Cell Physiol 204: 522-531.
26. Graeven U, Rodeck U, Karpinski S, Jost M, Andre N, Schmiegel W. 2000. Expression patterns of placenta growth factor in human melanocytic cell lines. J Invest Dermatol 115: 118-123.
27. Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM. 1996. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J 15: 3621-3632.
28. Jackson RS, Cho Y, Liang P. 2006. TIS11D is a candidate pro-apoptotic p53 target gene. Cell Cycle 5: 2889-2893.
29. Jurek A, Amagasaki K, Gembarska A, Heldin C, Lennartsson J. 2009. Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation. J Biol Chem 284: 4626-4634.
30. Klock A, Herrmann BG. 2002. Cloning and expression of the mouse dual-specificity mitogen-activated protein (MAP) kinase phosphatase Mkp3 during mouse embryogenesis. Mech Dev 116: 243-247.
31. Kuwano Y, Kim HH, Abdelmohsen K, Pullmann R, Martindale JL, Yang X, Gorospe M. 2008. MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol Cell Biol 28: 4562-4575.
32. Laderoute KR, Mendonca HL, Calaoagan JM, Knapp AM, Giaccia AJ, Stork PJ. 1999. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity. J Biol Chem 274: 12890-12897.
33. Lee M, Hook B, Pan G, Kershner AM, Merritt C, Seydoux G, Thomson JA, Wickens M, Kimble J. 2007. Conserved regulation of MAP kinase expression by PUF RNA-binding proteins. PLoS Genet 3: e233.
34. Lin N, Lin C, Chen Y, Chang C. 2007. Regulation of tristetraprolin during differentiation of 3T3-L1 preadipocytes. FEBS J 274: 867-878.
35. Lin N, Lin C, Chang C. 2008. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 365: 69-74.
36. Liu LX, Lu H, Luo Y, Date T, Belanger AJ, Vincent KA, Akita GY, Goldberg M, Cheng SH, Gregory RJ, Jiang C. 2002. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem Biophys Res Commun 291: 908-914.
37. Liu C, Shi Y, Han Z, Pan Y, Liu N, Han S, Chen Y, Lan M, Qiao T, Fan D. 2003. Suppression of the dual-specificity phosphatase MKP-1 enhances HIF-1 trans-activation and increases expression of EPO. Biochem Biophys Res Commun 312: 780-786.
38. Liu C, Shi Y, Du Y, Ning X, Liu N, Huang D, Liang J, Xue Y, Fan D. 2005. Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK. Exp Cell Res 309: 410-418.
39. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JGN, Semenza GL. 2005. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669.
40. Marchetti S, Gimond C, Chambard J, Touboul T, Roux D, Pouysségur J, Pagès G. 2005. Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 97, two sites critical for its proteasomal degradation. Mol Cell Biol 25: 854-864.
41. Mishra OP, Delivoria-Papadopoulos M. 2004. Effect of hypoxia on the expression and activity of mitogen-activated protein (MAP) kinase-phosphatase-1 (MKP-1) and MKP-3 in neuronal nuclei of newborn piglets: The role of nitric oxide. Neuroscience 129: 665-673.
42. Muda M, Theodosiou A, Gillieron C, Smith A, Chabert C, Camps M, Boschert U, Rodrigues N, Davies K, Ashworth A, et al. 1998. The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity. J Biol Chem 273: 9323-9329.
43. Mylonis I, Chachami G, Samiotaki M, Panayotou G, Paraskeva E, Kalousi A, Georgatsou E, Bonanou S, Simos G. 2006. Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J Biol Chem 281: 33095-33106.
44. Owens DM, Keyse SM. 2007. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26: 3203-3213.
45. Pramanik K, Chun CZ, Garnaas MK, Samant GV, Li K, Horswill MA, North PE, Ramchandran R. 2009. Dusp-5 and Snrk-1 coordinately function during vascular development and disease. Blood 113: 1184-1191.
46. Pumiglia KM, Decker SJ. 1997. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94: 448-452.
47. Ravi RK, Weber E, McMahon M, Williams JR, Baylin S, Mal A, Harter ML, Dillehay LE, Claudio PP, Giordano A, et al. 1998. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest 101: 153-159.
48. Richard DE, Berra E, Gothié E, Roux D, Pouysségur J. 1999. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274: 32631-32637.
49. Rintelen F, Hafen E, Nairz K. 2003. The Drosophila dual-specificity ERK phosphatase DMKP3 cooperates with the ERK tyrosine phosphatase PTP-ER. Development 130: 3479-3490.
50. Seta KA, Kim R, Kim HW, Millhorn DE, Beitner-Johnson D. 2001. Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis. J Biol Chem 276: 44405-44412.
51. Smith TG, Karlsson M, Lunn JS, Eblaghie MC, Keenan ID, Farrell ER, Tickle C, Storey KG, Keyse SM. 2006. Negative feedback predominates over cross-regulation to control ERK MAPK activity in response to FGF signalling in embryos. FEBS Lett 580: 4242-4245.
52. Spassov DS, Jurecic R. 2003. The PUF family of RNA-binding proteins: Does evolutionarily conserved structure equal conserved function? IUBMB Life 55: 359-366.
53. Takano S, Fukuyama H, Fukumoto M, Hirashimizu K, Higuchi T, Takenawa J, Nakayama H, Kimura J, Fujita J. 1995. Induction of CL100 protein tyrosine phosphatase following transient forebrain ischemia in the rat brain. J Cereb Blood Flow Metab 15: 33-41.
54. Tsang M, Maegawa S, Kiang A, Habas R, Weinberg E, Dawid IB. 2004. A role for MKP3 in axial patterning of the zebrafish embryo. Development 131: 2769-2779.
55. Warmka JK, Mauro LJ, Wattenberg EV. 2004. Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras. J Biol Chem 279: 33085-33092.